Author:
Vu Peter D.,Bansal Vishal,Chitneni Ahish,Robinson Christopher L.,Viswanath Omar,Urits Ivan,Kaye Alan D.,Nguyen Anvinh,Govindaraj Ranganathan,Chen Grant H.,Hasoon Jamal
Publisher
Springer Science and Business Media LLC
Subject
Anesthesiology and Pain Medicine,Neurology (clinical),General Medicine
Reference101 articles.
1. Dahlhamer J, Lucas J, Zelaya, Carla, et al. Prevalence of chronic pain and high-impact chronic pain among adults — United States, 2016. MMWR Morb Mortal Wkly Rep. 2018;67(36):1001–1006. https://doi.org/10.15585/mmwr.mm6736a2.
2. Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2017 National Survey on Drug Use and Health. U.S. Department of Health and Human Services.
3. Rosenblum A, Marsch LA, Joseph H, Portenoy RK. Opioids and the treatment of chronic pain: controversies, current status, and future directions. Exp Clin Psychopharmacol. 2008;16(5):405–16. https://doi.org/10.1037/a0013628.
4. Dalal S, Chitneni A, Berger AA, et al. Buprenorphine for chronic pain: a safer alternative to traditional opioids. Health Psychol Res. 2021;9(1). https://doi.org/10.52965/001c.27241.
5. Poliwoda S, Noor N, Jenkins JS, et al. Buprenorphine and its formulations: a comprehensive review. Health Psychol Res. 2022;10(3). https://doi.org/10.52965/001c.37517.